Inserisci dominio


← Click per aggiornare

nimml.org

nimml.org

Analisi sito web nimml.org

 Generato il Marzo 02 2026 07:04 AM

Statistiche non aggiornate? AGGIORNA !


Il punteggio e 53/100

Scarica la versione PDF

SEO Content

Title

Nutritional Immunology and Molecular Medicine Laboratory



Lunghezza : 56

Perfetto, il tuo title contiene tra 10 e 70 caratteri.
Description

The NIMML tackles unsolved challenges in complex human diseases with unmet clinical needs. We combine advanced computational technologies with pre-clinical and clinical experimentation to catalyze translation of scientific discoveries into commercial applications that address unmet clinical or consumer needs.



Lunghezza : 310

Idealmente, la tua meta description dovrebbe contenere tra 70 e 160 caratteri (spazi inclusi). Usa questo strumento free per calcolare la lunghezza del testo.
Keywords

nimml, Data Science, Artificial Intelligence, Crohn's Disease, helicobacter pylori, science, Precision Medicines, Ulcerative colitis, Immunology



Buono, la tua pagina contiene meta keywords.
Og Meta Properties Questa pagina non sfrutta i vantaggi Og Properties. Questi tags consentono ai social crawler di strutturare meglio la tua pagina. Use questo generatore gratuito di og properties per crearli.
Headings
H1 H2 H3 H4 H5 H6
0 5 12 0 0 21
  • [H2] In The News
  • [H2] Translational and Clinical Science
  • [H2] Entrepreneurship
  • [H2] Modeling and AI
  • [H2] Follow @NIMMLab on Twitter
  • [H3] The NIMML Institute and NImmune Biopharma Showcase How the TITAN-X A.I. Platform has Accelerated Therapeutic Development in the Annual Review of Biomedical Data Science
  • [H3] NIMML Institute to Present Novel Clinical and Translational Data of Omilancor in Ulcerative Colitis Patients at Digestive Disease Week 2025
  • [H3] The NIMML Institute and NImmune Biopharma Announce Publication of New Mechanistic Insights on the Immunometabolic Control of Systemic Lupus Erythematosus in the Journal of Immunology
  • [H3] The NIMML Institute and NImmune Biopharma Announce Publication of Positive First-in-Human Data of NIM-1324, a Phase 2 Candidate for Systemic Lupus Erythematosus, in Clinical and Translational Science
  • [H3] NIMML Presents Positive First-in-Human Data of NIM-1324, a Phase 2 Candidate for Systemic Lupus Erythematosus at the American College of Rheumatology Convergence 2023 (#ACR23)
  • [H3] NIMML Announces Positive Results of Omilancor Clinical Trials in Ulcerative Colitis and Crohn’s Disease at the American College of Gastroenterology 2023 Annual Scientific Meeting
  • [H3] NIMML Institute and NImmune Biopharma Partner to Advance Precision Medicine Research for Autoimmune Diseases
  • [H3] The NIMML Institute Founder Launches NImmune Biopharma to Develop Late-Stage Breakthrough Immunoregulatory Medicines for Autoimmune Diseases
  • [H3] Landos Biopharma to Present at the 38th Annual J.P. Morgan Healthcare Conference
  • [H3] NIMML Announces Publication of New Mechanistic Insights on the Metabolic Control of Inflammation and Infection in Scientific Reports
  • [H3] NIMML Launches A.I. Powered TITAN-X Platform to Accelerate Development of Precision Immunology Therapeutics
  • [H3] The NIMML Institute Launches New Tool for Rapidly Analyzing Host Metabolic Profiles from Global Transcriptomics Datasets
  • [H6] Clinical
  • [H6] Pig Models
  • [H6] Media & Press Kit
  • [H6] ENISI Helicobacter Pylori Model
  • [H6] CDiff Computational Model Archive
  • [H6] EAEC Computational Model
  • [H6] Macrophage Computational Model Archive
  • [H6] COPASI Helicobacter Pylori Computational Model Archive
  • [H6] CD4+ T Cell Model Archive
  • [H6] Immunology
  • [H6] Animal Models
  • [H6] Infectious Diseases
  • [H6] Immune Mediated Diseases
  • [H6] Nutritional Immunology
  • [H6] Drug Development
  • [H6] Data
  • [H6] Computational Models
  • [H6] Tools
  • [H6] Projects
  • [H6] Immunoinformatics
  • [H6] NIMML POLICIES
Images Abbiamo trovato 17 immagini in questa pagina web.

16 attributi alt sono vuoti o mancanti. Aggiungi testo alternativo in modo tale che i motori di ricerca possano comprendere meglio il contenuto delle tue immagini.
Text/HTML Ratio Ratio : 28%

Ideale! Il rapporto testo/codice HTML di questa pagina e tra 25 e 70 percento.
Flash Perfetto, non e stato rilevato contenuto Flash in questa pagina.
Iframe Grande, non sono stati rilevati Iframes in questa pagina.

URL Rewrite Buono. I tuoi links appaiono friendly!
Underscores in the URLs Abbiamo rilevato underscores nei tuoi URLs. Dovresti utilizzare trattini per ottimizzare le pagine per il tuo SEO.
In-page links Abbiamo trovato un totale di 96 links inclusi 4 link(s) a files



Anchor Type Juice
Menu Interno Passing Juice
About Interno Passing Juice
Team Interno Passing Juice
Research Interno Passing Juice
Modeling Interno Passing Juice
Clinical Interno Passing Juice
Projects Interno Passing Juice
News Interno Passing Juice
Publications Interno Passing Juice
Careers Interno Passing Juice
Applying AI to unravel the complexity of the immune system as a massively and dynamically interacting system. Interno Passing Juice
The NIMML Institute and NImmune Biopharma Showcase How the TITAN-X A.I. Platform has Accelerated Therapeutic Development in the Annual Review of Biomedical Data Science Interno Passing Juice
NIMML Institute to Present Novel Clinical and Translational Data of Omilancor in Ulcerative Colitis Patients at Digestive Disease Week 2025 Interno Passing Juice
The NIMML Institute and NImmune Biopharma Announce Publication of New Mechanistic Insights on the Immunometabolic Control of Systemic Lupus Erythematosus in the Journal of Immunology Interno Passing Juice
View All Interno Passing Juice
The NIMML Institute and NImmune Biopharma Announce Publication of Positive First-in-Human Data of NIM-1324, a Phase 2 Candidate for Systemic Lupus Erythematosus, in Clinical and Translational Science Interno Passing Juice
NIMML Presents Positive First-in-Human Data of NIM-1324, a Phase 2 Candidate for Systemic Lupus Erythematosus at the American College of Rheumatology Convergence 2023 (#ACR23) Interno Passing Juice
NIMML Announces Positive Results of Omilancor Clinical Trials in Ulcerative Colitis and Crohn’s Disease at the American College of Gastroenterology 2023 Annual Scientific Meeting Interno Passing Juice
View All Interno Passing Juice
NIMML Institute and NImmune Biopharma Partner to Advance Precision Medicine Research for Autoimmune Diseases Interno Passing Juice
The NIMML Institute Founder Launches NImmune Biopharma to Develop Late-Stage Breakthrough Immunoregulatory Medicines for Autoimmune Diseases Interno Passing Juice
Landos Biopharma to Present at the 38th Annual J.P. Morgan Healthcare Conference Interno Passing Juice
View All Interno Passing Juice
NIMML Announces Publication of New Mechanistic Insights on the Metabolic Control of Inflammation and Infection in Scientific Reports Interno Passing Juice
NIMML Launches A.I. Powered TITAN-X Platform to Accelerate Development of Precision Immunology Therapeutics Interno Passing Juice
The NIMML Institute Launches New Tool for Rapidly Analyzing Host Metabolic Profiles from Global Transcriptomics Datasets Interno Passing Juice
Tweets by @NIMMLab Externo Passing Juice
Follow @NIMMLab on Twitter Interno Passing Juice
Contact Interno Passing Juice
Education Interno Passing Juice
Neonatal pig model Interno Passing Juice
Inflammatory bowel disease Interno Passing Juice
Mission, Vision, Values Interno Passing Juice
History Interno Passing Juice
Quick Facts Interno Passing Juice
Strategic Initiatives Interno Passing Juice
Sensitivity Analysis Interno Passing Juice
Cell Movement Modeling Interno Passing Juice
Mucosal Immune Responses Interno Passing Juice
PPAR γ and miRNA Interno Passing Juice
Mucosal Immune Responses Interno Passing Juice
T Cell Response Interno Passing Juice
Epithelial Cell Responses Interno Passing Juice
April 2012 Interno Passing Juice
Jan 2012 Interno Passing Juice
Oct 2011 Interno Passing Juice
May 2012 Interno Passing Juice
April 2012 Interno Passing Juice
Jan 2012 Interno Passing Juice
Sep 2011 Interno Passing Juice
Feb 2014 Interno Passing Juice
October 2012 Interno Passing Juice
August 2012 Interno Passing Juice
April 2012 Interno Passing Juice
Jan 2012 Interno Passing Juice
Sep 2011 Interno Passing Juice
June 2011 Interno Passing Juice
March 2011 Interno Passing Juice
CD4+ T cell differentiation Interno Passing Juice
Human Studies Interno Passing Juice
Type 2 Diabetes Interno Passing Juice
Influenza Interno Passing Juice
Inflammatory bowel disease Interno Passing Juice
Pig Models Interno Passing Juice
Murine Models Interno Passing Juice
Novel IBD Interventions Interno Passing Juice
Novel IBD Interventions Interno Passing Juice
Phytochemicals Interno Passing Juice
Dietary Lipids Interno Passing Juice
Prebiotics and Probiotics Interno Passing Juice
Host-targeted Therapeutics Interno Passing Juice
Translational Medicine Interno Passing Juice
Modeling Clostridium difficile Immune Response Interno Passing Juice
EAEC Zinc Deficiency Interno Passing Juice
IL-21 in the Gastric Mucosa Interno Passing Juice
Novel Pig Model Interno Passing Juice
CD4+ T Cells Interno Passing Juice
Inflammatory bowel disease Interno Passing Juice
CD4+ T Cell Model Interno Passing Juice
Host Responses to EAEC Interno Passing Juice
Macrophages Interno Passing Juice
CMS Interno Passing Juice
CellDesigner Interno Passing Juice
ENISI Suite Interno Passing Juice
COPASI Suite Interno Passing Juice
Galaxy Interno Passing Juice
LabKey Interno Passing Juice
RedCap Interno Passing Juice
Intranet Interno Passing Juice
CellPublisher Interno Passing Juice
Alternate Preclinical Models Of Enteric Infection Interno Passing Juice
Modeling Infectious Disease Kinetics (MIDK-cWMD) Interno Passing Juice
Computational Modeling Interno Passing Juice
High Performance Computing Interno Passing Juice
Transcriptomics Interno Passing Juice
FCOI Interno Passing Juice

SEO Keywords

Keywords Cloud pylori computational cell modeling responses models pig immune model nimml
Consistenza Keywords
Keyword Contenuto Title Keywords Description Headings
model 10
modeling 8
pylori 8
nimml 7
computational 6

Usabilita

Url Dominio : nimml.org
Lunghezza : 9
Favicon Grande, il tuo sito usa una favicon.
Stampabilita Non abbiamo riscontrato codice CSS Print-Friendly.
Lingua Non hai specificato la lingua. Usa questo generatore gratuito di meta tags generator per dichiarare la lingua che intendi utilizzare per il tuo sito web.
Dublin Core Questa pagina non sfrutta i vantaggi di Dublin Core.

Documento

Doctype HTML 5
Encoding Perfetto. Hai dichiarato che il tuo charset e UTF-8.
Validita W3C Errori : 0
Avvisi : 0
Email Privacy Grande. Nessun indirizzo mail e stato trovato in plain text!
Deprecated HTML Grande! Non abbiamo trovato tags HTML deprecati nel tuo codice.
Suggerimenti per velocizzare
Eccellente, il tuo sito web non utilizza nested tables.
Molto male, il tuo sito web utilizza stili CSS inline.
Molto male, il tuo sito web ha troppi file CSS files (piu di 4).
Molto male, il tuo sito web ha troppi file JS (piu di 6).
Peccato, il vostro sito non approfitta di gzip.

Mobile

Mobile Optimization
Apple Icon
Meta Viewport Tag
Flash content

Ottimizzazione

XML Sitemap Non trovato

Il tuo sito web non ha una sitemap XML - questo può essere problematico.

A elenca sitemap URL che sono disponibili per la scansione e possono includere informazioni aggiuntive come gli ultimi aggiornamenti del tuo sito, frequenza delle variazioni e l'importanza degli URL. In questo modo i motori di ricerca di eseguire la scansione del sito in modo più intelligente.
Robots.txt http://nimml.org/robots.txt

Grande, il vostro sito ha un file robots.txt.
Analytics Grande, il vostro sito ha uno strumento di analisi dei dati.

   Google Analytics

PageSpeed Insights


Analisi